Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Investors Should Take Notice of Congressional Questions Regarding Nuedexta Pricing
Investors Should Take Notice of Congressional Questions Regarding Nuedexta Pricing
Investors Should Take Notice of Congressional Questions Regarding Nuedexta Pricing
Submitted by
admin
on May 27, 2011 - 10:54am
Source:
Seeking Alpha
News Tags:
investors
Nuedexta
PBA
Avanir
drug pricing
Headline:
Investors Should Take Notice of Congressional Questions Regarding Nuedexta Pricing
Do Not Allow Advertisers to Use My Personal information
